Conformational partitioning of the fusion peptide of HIV-1 gp41 and its structural analogs in bilayer membranes

Biophysical Journal

Volumn 83, Issue 6, 2002, Pages 3088-3096

  Maddox, Michael W ^a   Longo, Marjorie L ^a  

^a University of California   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; GLYCOPROTEIN 41; HYBRID PROTEIN; MUTAGENIC AGENT; PROTEIN DERIVATIVE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; BILAYER MEMBRANE; ENERGY; ENTROPY; ERYTHROCYTE; GEOMETRY; HEMOLYSIS; HUMAN IMMUNODEFICIENCY VIRUS 1; HYDROPHOBICITY; LIPID BILAYER; MEMBRANE MODEL; MONTE CARLO METHOD; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN INTERACTION; QUANTITATIVE ANALYSIS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0036932204     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3495(02)75313-7     Document Type: Article

References (18)

1. Bergeron, L., N. Sullivan, and J. Sodroski. 1992. Target cell-specific determinants of membrane fusion within the human immunodeficiency virus type 1 gp120 third variable region and gp41 amino terminus. J. Virol. 66:2389-2397.
2. Bradshaw, J. P., M. J. Darkes, T. A. Harroun, J. Katrsaras, and R. M. Epand. 2000. Oblique membrane insertion of viral fusion peptide probed by neutron diffraction. Biochemistry. 39:6581-6585.
3. Brasseur, R., M. Vandenbranden, B. Cornet, A. Burny, and J. M. Ruysshaert. 1990. Orientation into the lipid bilayer of an asymmetric amphipathic helical peptide located at the N terminus of viral fusion proteins. Biochim. Biophys. Acta. 1029:267-273.
4. Buchschacher, Jr., G. L., E. O. Freed, and A. T. Panganbian. 1995. Effects of second-site mutations on dominant interference by a human immunodeficiency virus type 1 envelope glycoprotein mutant. J. Virol. 69:1344-1348.
5. Cao, J., L. Bergeron, E. Helseth, M. Thali, H, Repke, and J. Sodroski. 1993. Effects of amino acid changes in the extracellular domain of the human immunodeficiency virus type 1 gp41 envelope glycoprotein. J. Virol. 67:2747-2755.
6. Epand, R. M., and R. F. Epand. 2000. Modulation of membrane curvature by peptides. Biopolymers. 55:358-363.
7. Felser, J. M., T. Klimkait, and J. Silver. 1989. A syncytia assay for human immunodeficiency virus type 1 (HIV-1) envelope protein and its use in studying HIV-1 mutations. Virology. 170:566-570.
8. Freed, E. O., E. L. Delwart, G. L. Buchschacher, and A. T. Panganiban, 1992. A mutation in the immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity. Proc. Natl. Acad. Sci. U. S. A. 89:70-74.
9. Freed, E. O., D. J. Myers, and R. Risser. 1990. Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41. Proc. Natl. Acad. Sci. U. S. A. 87:4650-4654.
10. Gordon, L. M., C. C. Curtain, Y. C. Zhong, A. Kirkpatrick, P. W. Mobley, and A. J. Waring. 1992. The amino-terminal peptide of HIV-1 glycoprotein gp41 interacts with human erythrocyte membranes: Peptide conformation, orientation and aggregation. Biochim. Biophys. Acta. 1139:257-274.
11. Griffith, O. H., P. H. Dehlinger, and S. P. Van. 1974. Shape of the hydrophobic barrier of phospholipid bilayers (evidence of water penetration). J. Membr. Biol. 15:159-192.
12. Maddox, M. W., and M. L. Longo. 2002. A Monte Carlo study of peptide insertion into lipid bilayers: equilibrium conformations and insertion mechanisms. Biophys. J. 82:244-263.
13. Martin, I., H. Schaal, A. Scheid, and J. Ruysschaert. 1996. Lipid membrane fusion induced by the human immunodeficiency virus type 1 gp41 N-terminal extremity is determined by its orientation in the lipid bilayer. J. Virol. 70:298-304.
14. Mobley, P. W., A. J. Waring, M. A. Sherman, and L. M. Gordon. 1999. Membrane interactions of the synthetic N-terminal peptide of HIV-1 gp41 and its structural analogs. Biochim. Biophys. Acta. 1418:1-18.
15. Peisajovich, S. G., R. F. Epand, M. Pritsker, Y. Shai, and R. M. Epand. 2000. The polar region consecutive to the HIV fusion peptide participates in membrane fusion. Biochemistry. 39:1826-1833.
16. Pereira, F. B., F. M. Goñi, A. Muga, and J. L. Nieva. 1997. Permeabilization and fusion of uncharged lipid vesicles induced by the HIV-1 fusion peptide adopting an extended conformation: Dose and sequence effects. Biophys. J. 73:1977-1986.
17. Roseman, M. A. 1988. Hydrophilicity of polar amino acid side-chains is markedly reduced by flanking peptide bonds. J. Mol. Biol. 200:513-522.
18. Schaal, H., M. Klein, P. Gerhmann, O. Adams, and A. Scheid. 1995. Requirement of N-terminal amino acid residues of gp41 for human immunodeficiency virus type 1-mediated cell fusion. J. Virol. 69:3308-3314.